Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
about
The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewTargeting the Brain Reservoirs: Toward an HIV CureTemporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected AdultsCROI 2017: Neurologic Complications of HIV Infection.Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.HIV, Tat and dopamine transmission.Neurologic Complications in Treated HIV-1 Infection.Evaluation of cerebrospinal fluid virological escape in patients on long-term protease inhibitor monotherapy.Treating HIV Infection in the Central Nervous System.Neurocognition with maraviroc compared with tenofovir in HIV.HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy.Chimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection.HIV positive patient with GBS-like syndrome.Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA.Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection.Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia.Neurosymptomatic cerebrospinal fluid escape in HIV-2: a case report.Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.Human Immunodeficiency Virus in the Brain-Culprit or Facilitator?Global HIV neurology: a comprehensive review.Impact of Antiretroviral Regimens on CSF Viral Escape in a Prospective Multicohort Study of ART-Experienced HIV-1 Infected Adults in the United States.Highlights from the HIV Cure and Reservoir Symposium, 11-12 September 2017, Ghent, Belgium.
P2860
Q28066725-6ECEF5FE-1E27-4487-B0BA-A85A61BBE743Q28075694-09BF6E09-8772-4E46-8F56-CB2C45C7D4D1Q33750994-08CF6C8F-5018-4C3F-AE2E-D90E3BC00C99Q38734143-8E397A4D-AD20-43CA-8AAE-74225BB81716Q38734471-98DAF433-998E-46E6-BE34-F1ED562A6154Q38812005-848F0F44-E458-4A72-97EB-B31C544E3AA5Q38832560-AD6A1F99-8583-43E5-BA3A-FA8DF289F7CFQ38879115-1C8A94FC-E780-47CB-AA1A-02819B669CC8Q39077816-A6D4438B-56BD-4054-A252-56372BF1FD1FQ39402373-E1491612-2028-4B3B-A5B7-7704458808CDQ39548875-6E603E42-D96E-413C-858D-B49AA8C09884Q40472266-A61BA521-1794-4988-BD73-9448A9773C96Q42363071-1DE2025E-F604-4541-86AC-22CB38B816F4Q42380879-887D8AFE-DD85-4532-9EE0-C962AB8B2541Q45325864-42D4E50D-012C-498E-9C7B-6FB5AE3EC3CCQ46229748-AEBF6A2E-4260-4345-BD11-2AB5F2190B3AQ47564644-34848D9B-7E41-41CE-9EE5-08282BE22799Q49689948-EE6BD218-A8A0-420F-A8D8-47368DA8C090Q49711913-A94CF977-4C51-40B7-BDB6-C6ABF51C16CBQ50200827-5BCEA3E4-D220-4064-8514-84C7D3038182Q51762497-6C355321-AE35-40B3-89FF-83E1B6A63D1AQ52607097-BDF24A03-F0C9-4386-A350-C538843BC255Q55394853-309B45D1-9514-40F2-90F9-21BBE6B165D8
P2860
Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
@en
type
label
Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
@en
prefLabel
Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
@en
P2093
P2860
P1476
Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
@en
P2093
Francesca Ferretti
Magnus Gisslen
Paola Cinque
Richard W Price
P2860
P2888
P304
P356
10.1007/S11904-015-0267-7
P577
2015-06-01T00:00:00Z